as Andrew says in the piece, "So we've begun clinical testing in March, earlier this year. So we're still in early days of the actual clinical testing. We've tested it in about 100 people. The results look pretty good. It looks like we are reducing the amount of bacteria associated with the particular devices..."
Early days
as Andrew says in the piece, "So we've begun clinical testing in March, earlier this year. So we're still in early days of the actual clinical testing. We've tested it in about 100 people. The results look pretty good. It looks like we are reducing the amount of bacteria associated with the particular devices..."